RESEARCH TRIANGLE PARK, N.C. — October 7, 2026
IQVIA (NYSE: IQV), a global provider of clinical research services, commercial insights and healthcare intelligence, introduced IQVIA Explorer™ at TechIQ 2026 to help life sciences companies make faster, better-informed commercial decisions. The platform transforms one-time analytics projects into an always-on commercial intelligence capability, combining IQVIA data, analytical methods and workflows to deliver near-real-time insights. By enabling teams to respond more quickly to changing market conditions, Explorer aims to improve commercial execution, identify opportunities and support stronger return on investment.
Brand Performance Analysis in Minutes
IQVIA Explorer enables commercial teams to assess where brands are gaining or losing market share by analyzing treatment starts, switching patterns and discontinuation across patient populations. According to IQVIA, analyses that previously took several weeks can now be completed in an average of less than 15 minutes. These insights can help teams identify changes in treatment behavior, evaluate brand performance and respond more quickly to emerging market trends, reducing the time required to turn complex data into actionable commercial intelligence..
Faster Resource Planning and Scenario Testing
The platform also combines market, treatment and provider-level trends to help companies identify areas of opportunity and allocate commercial resources more effectively. IQVIA reports that resource-planning analyses can be completed in less than one hour, compared with the two to three weeks traditionally required. Teams can also modify assumptions, such as patient populations and market definitions, and rerun analyses in approximately four minutes to two hours rather than initiating a new multi-week project. This flexibility is designed to support more responsive planning and faster evaluation of commercial strategies.
Advertisement
IQVIA Expands Data-Driven Commercial Solutions
IQVIA Explorer extends the company’s commercial intelligence capabilities by bringing together its data foundation and advanced analytics in a workflow designed for ongoing decision support. Pete Groves, executive vice president of AI and Technology Solutions at IQVIA, said the platform helps customers understand current performance and model potential future outcomes more quickly. The launch reflects the growing role of data-driven analytics and AI-enabled intelligence in pharmaceutical commercialization, where teams face complex markets, changing treatment patterns and pressure to improve productivity. IQVIA aims to help life sciences organizations make more timely decisions and strengthen commercial performance.
Source::IQVIA, press release
